Growing investment in pharmaceutical research, biotechnology, advanced materials, and industrial quality control is supporting the adoption of particle characterization solutions across North America. Companies and laboratories require accurate measurement technologies to assess material properties, improve formulations, and maintain consistent production standards. Laser diffraction and dynamic light scattering systems, along with imaging and nanoparticle analysis platforms, are increasingly being incorporated into analytical workflows. The US provides substantial opportunities due to its mature research infrastructure and demand for advanced laboratory technologies.
The global Particle Size Analysis Market Size is projected to reach US$ 618.49 million by 2034 from US$ 495.28 million in 2025, registering a CAGR of 2.82% during 2026–2034. Within this landscape, North America remains an important region, with the US serving as a key market supported by pharmaceutical research, advanced manufacturing, stringent quality requirements, and continued development of analytical technologies. Particle size characterization is particularly relevant to pharmaceutical formulation and generic drug development, where particle dimensions can influence dissolution, bioavailability, stability, and product performance.
Download Sample PDF Link:https://www.theinsightpartners.com/sample/TIPRE00012548
North America Emerges as a Key Region for Particle Characterization
North America's established pharmaceutical, biotechnology, chemical, food, and research industries provide a broad application base for particle characterization technologies. Laboratories and manufacturers increasingly require instruments that can deliver reproducible measurements across different particle ranges and sample types. The presence of sophisticated research infrastructure and established analytical-equipment suppliers further supports technology adoption.
The US represents a particularly important opportunity because particle characterization is closely connected with pharmaceutical development and quality-control activities. The US Food and Drug Administration (FDA) has highlighted particle size characterization as an important analytical consideration for complex drug products. In September 2025, the FDA's Center for Research on Complex Generics conducted a workshop specifically focused on particle size analysis, including Dynamic Light Scattering and Laser Diffraction techniques, method development, and validation.
Market Report Drivers
Growing Pharmaceutical Manufacturing and Drug Development in the US
The pharmaceutical industry is one of the principal application areas for particle size analysis. Particle size can influence dissolution, bioavailability, stability, and other performance characteristics of solid and suspension drug products. FDA guidance specifically recognizes circumstances in which particle-size distribution testing is appropriate for drug products, including oral and injectable suspensions.
This creates sustained demand for analytical systems capable of accurately characterizing active pharmaceutical ingredients, excipients, suspensions, emulsions, and other complex formulations. The US focus on strengthening domestic pharmaceutical manufacturing may further expand opportunities for analytical technologies used during research, formulation development, process development, and quality control. In 2026, the FDA's PreCheck Pilot Program was introduced to support new domestic pharmaceutical manufacturing facilities and strengthen the US pharmaceutical supply chain.
Increasing Need for Accurate and Reproducible Measurements
Accuracy and reproducibility are central requirements for laboratories operating in highly regulated industries. Modern laser diffraction and DLS instruments provide faster measurements, broader analytical capabilities, and improved automation compared with conventional laboratory approaches.
For US pharmaceutical companies and research organizations, the ability to generate reliable particle-size distribution data is particularly important when developing generic, complex, and nanoparticle-based products. FDA research has also examined advanced approaches for characterizing nanoparticles because conventional light-scattering methods can face limitations when measuring particle-size distributions and composition.
Technological Advancements in Analytical Instruments
Technology development is another important driver across North America. The global report identifies laser diffraction, DLS, static analysis, dynamic imaging, Coulter principle, and nanoparticle tracking among the major technologies covered. These approaches serve different particle ranges and application requirements, allowing laboratories to select analytical methods according to material characteristics and testing objectives.
Increasing automation is also influencing purchasing decisions. Automated sample handling, software-based analysis, improved data management, and online or in-situ measurement capabilities can help manufacturers reduce manual intervention and obtain faster feedback during production. These developments are particularly relevant to pharmaceutical and chemical facilities seeking greater process control.
Opportunities Across US Pharmaceuticals and Advanced Materials
The US opportunity extends beyond conventional pharmaceutical testing. Nanotechnology, advanced materials, specialty chemicals, food ingredients, coatings, and research applications also require accurate characterization of particle dimensions and distributions.
The development of complex generic drugs represents a notable application area. The FDA has identified the need for sensitive and specific particle-size characterization methods, including laser diffraction, optical microscopy, and electron microscopy, for complex products such as emulsions, suspensions, liposomes, and microspheres.
This creates opportunities for analytical technology providers offering integrated platforms that can characterize particle size, shape, distribution, and related physical properties. As US laboratories pursue faster development cycles, measurement technologies that combine multiple analytical capabilities can become increasingly relevant.
Technology and End-User Landscape
The Particle Size Analysis Market is segmented by technology into Laser Diffraction, DLS, Static, Dynamic Imaging, Coulter Principle, Nanoparticle Tracking, and Others. By dispersion type, the market covers Wet Dispersion, Dry Dispersion, and Spray Dispersion. By end user, the segments include Pharmaceutical, Chemical, Petroleum, Mining, Food, Academia, and Others.
In North America, pharmaceutical and academic applications are particularly relevant because of the region's extensive research ecosystem and advanced analytical requirements. Chemical, food, petroleum, and mining applications provide additional opportunities for instrument manufacturers as organizations increasingly prioritize material consistency and process efficiency.
Top Players in the Particle Size Analysis Market
The key companies profiled in the report include Anton Paar GmbH, Beckman Coulter, Inc., Bettersize Instruments Ltd., Brookhaven Instruments, DANDONG HMKTEST INSTRUMENT CO., LTD., Fritsch GmbH, HORIBA, Ltd., Malvern Panalytical Ltd., Microtrac Retsch GmbH, and Sympatec GmbH.
These companies compete through technology development, product innovation, application-specific solutions, automation, measurement accuracy, and expansion of analytical capabilities. For North American customers, the ability to support regulated pharmaceutical workflows and complex material characterization remains an important consideration.
Future Outlook for North America and the US
The outlook for particle characterization technologies in North America is closely linked to continued pharmaceutical innovation, advanced materials research, regulatory requirements, and modernization of manufacturing facilities. The US pharmaceutical sector's ongoing emphasis on domestic production and supply-chain resilience may create additional demand for analytical equipment used throughout formulation and manufacturing workflows.
As laboratories increasingly seek faster, more reliable, and multipurpose analytical workflows, suppliers that combine advanced measurement technologies with automation and sophisticated data analysis can address evolving requirements across the US and wider North American market.
About The Insight Partners
The Insight Partners is a global market research and consulting company providing industry research, market analysis, forecasts, competitive intelligence, and customized research solutions. Its research reports provide insights into market dynamics, growth drivers, trends, segmentation, competitive landscapes, and regional opportunities across multiple industries.
Contact Us
The Insight Partners
Email: sales@theinsightpartners.com
Phone: +1-646-491-9876
Website: https://www.theinsightpartners.com
Related Reports -
Submarine Fiber Cable Market Demand, Share & Growth by 2034
Automotive HVAC Market Size, Growth & Trends by 2034
Offshore Wind Cable Market Size, Growth & Trends by 2034